Tammy Huang

5PUBLICATIONS
81CO-AUTHORS
Molecular targetsFood properties (incl. characteristics and health benefits)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 26, 2025
CAR T cells based on fully human T cell receptor-mimetic antibodies exhibit potent antitumor activity in vivo.

Robert Salzler, David J DiLillo, Kei Saotome

|Jul 31, 2024
A Tetravalent Bispecific Antibody Selectively Inhibits Diverse FGFR3 Oncogenic Variants.

Yan Yang, Avvaru N Suhasini, Zaoli Jiang

|Nov 22, 2023
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency.

Judith Y Altarejos, Jeffrey Pangilinan, Simona Podgrabinska

|Jan 11, 2023
Blocking common γ chain cytokine signaling ameliorates T cell-mediated pathogenesis in disease models.

Audrey Le Floc'h, Kirsten Nagashima, Dylan Birchard

|Dec 28, 2019
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties.

Lynn E Macdonald, Karoline A Meagher, Matthew C Franklin

Pageof 1